CIK 0001557746 · Non-accelerated filer<br>Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460571712
- Phone
- 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-15 | Fair Brett Chief Commercial Officer | Shares withheld for taxes | −288 | $7.31 | $2K | 6,763 |
| 2018-12-15 | Fair Brett Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,013 | 2,025 | ||
| 2018-10-22 | Mehra Anand Director | Purchase | +372,093 | $10.75 | $4.0M | 1,911,573 |
| 2018-10-04 | Tullman Stephen A. Director | Purchase | +7,100 | $14.00 | $99K | 177,457 |
| 2018-08-23 | Tullman Stephen A. Director | Purchase | +6,600 | $15.00 | $99K | 170,357 |
| 2018-08-15 | Tullman Stephen A. Director | Purchase | +6,250 | $15.97 | $100K | 163,757 |
| 2018-06-12 | Ali-Jackson Kamil Chief Legal Officer | Sale | −4,900 | $20.00 | $98K | 77,636 |
| 2018-06-11 | Ali-Jackson Kamil Chief Legal Officer | Sale | −100 | $20.00 | $2K | 82,536 |
| 2018-06-07 | SCHIFF ANDREW N Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2018-06-07 | Powell Andrew Kenneth William Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2018-06-07 | Molineaux Christopher P. Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2018-06-07 | Humphries William D. Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2018-06-07 | Mehra Anand Director | Grant or award · Stock Option (right to buy) | +8,000 | 8,000 | ||
| 2018-05-18 | Ali-Jackson Kamil Chief Legal Officer | Sale | −10,000 | $20.00 | $200K | 82,636 |
| 2018-05-16 | Powell Andrew Kenneth William Director | Purchase | +500 | $19.12 | $10K | 500 |
| 2018-05-07 | Walker Neal President and CEO | Option exercise | +12,133 | 909,317 | ||
| 2018-05-07 | Walker Neal President and CEO | Shares withheld for taxes | −3,455 | $18.10 | $63K | 905,862 |
| 2018-05-07 | Walker Neal President and CEO | Option exercise · Restricted Stock Units | −12,133 | 9,100 | ||
| 2018-05-07 | Shanler Stuart Chief Scientific Officer | Option exercise | +5,200 | 268,992 | ||
| 2018-05-07 | Shanler Stuart Chief Scientific Officer | Shares withheld for taxes | −1,480 | $18.10 | $27K | 267,512 |
Page 45 of 47 · 928 trades